Unichem Laboratories has completed the sale of 19.97% equity shares in Optimus Drugs (Optimus) to Sekhmet Pharmaventures on September 22, 2022. The company has received payment of around Rs 270.98 crore towards completion of sale of first tranche. For the second tranche, the price to be determined as per the said share purchase agreement after satisfaction of necessary conditions precedent.
Incorporated on December 2, 2003, Optimus is engaged in the business of researching, developing, manufacturing, marketing, and distribution of active pharmaceutical ingredients and intermediates.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
